Britannia Pharmaceuticals
Britannia Pharmaceuticals is a pharmaceutical company that develops therapies for long-term neurological conditions, particularly Parkinson's disease and schizophrenia. They have over 30 years of experience in the field.
- Clinical trials funding
- Patient-centric technology
- Innovative specialty therapies
- High-quality ethical treatments